Nicola Pozzi, Ph.D.
Associate Professor & Secondary Associate Professor of Biomedical Engineering
Mechanisms of blood coagulation and Antiphospholipid Syndrome.
Research Interests
Our research focuses on the molecular mechanisms of thrombosis and hemostasis. We use biochemical and biophysical methods, like single-molecule fluorescence spectroscopy, protein engineering, non-canonical amino acids, cryo-EM, X-ray crystallography, and microfluidic technologies, to investigate how coagulation and complement factors operate and crosstalk during physiological conditions (i.e., hemostasis) and how their function is altered during pathological scenarios, leading to potentially life-threatening conditions like thrombosis (i.e., excessive formation of blood clots) and bleeding (i.e., inefficient formation of blood clots).
Basic knowledge inferred from these studies is used to explain patients’ clinical phenotypes, identify patients at higher risk of cardiovascular events and develop new strategies to restore hemostasis. While our approach is applicable to many disease states, most of our studies and research efforts are dedicated to advancing the diagnosis and treatment of Antiphospholipid Syndrome, a systemic autoimmune disorder resulting in life-threatening blood clots for which there is no cure.
Recent Publications
N-glycosylation in the SERPIN domain of C1-Esterase Inhibitor in hereditary angioedema
N-glycosylation in the SERPIN domain of C1-Esterase Inhibitor in hereditary angioedema
Hereditary angioedema is an autosomal dominant disorder caused by defects in C1-esterase inhibitor (C1-INH), resulting in poorly controlled activation of the kallikrein-kinin system and bradykinin overproduction. C1-INH is a heavily glycosylated protein in the serine protease inhibitor (SERPIN) family, yet the role of these glycosylation sites remains unclear. To elucidate the functional impact of N-glycosylation in the SERPIN domain of C1-INH, we engineered four sets consisting of 26 variants at or near the N-linked sequon (NXS/T). Among these, six are reported in HAE patients and five are known C1-INH variants without accessible clinical histories. We systematically evaluated their expression, structure and functional activity with C1¯s, FXIIa and kallikrein. Our findings showed that of the eleven reported variants, seven are deleterious. Deleting N at the three naturally occurring N-linked sequons (N238, N253 and N352) results in pathologic consequences. Altering these sites by substituting N to A disrupts N-linked sugar attachment but preserves protein expression or function. Further, an additional N-linked sugar generated at N272 impairs C1-INH function. These findings highlight the importance of N-linked sequons in modulating the expression and function of C1-INH. Insights gained from identifying the pathological consequences of N-glycan variants should assist in defining more tailored therapy.
The strand exchange domain of tumor suppressor PALB2 is intrinsically disordered and promotes oligomerization-dependent DNA compaction
The strand exchange domain of tumor suppressor PALB2 is intrinsically disordered and promotes oligomerization-dependent DNA compaction
The partner and localizer of BRCA2 (PALB2) is a scaffold protein linking BRCA1 with BRCA2 and RAD51 during homologous recombination (HR). PALB2 interaction with DNA strongly enhances HR in cells, while the PALB2 DNA-binding domain (PALB2-DBD) supports DNA strand exchange . We determined that PALB2-DBD is intrinsically disordered beyond a single N-terminal α-helix. Coiled-coil mediated dimerization is stabilized by interaction between intrinsically disordered regions (IDRs) leading to a 2-fold structural compaction. Single-stranded (ss)DNA binding promotes additional structural compaction and protein tetramerization. Using confocal single-molecule FRET, we observed bimodal and oligomerization-dependent compaction of ssDNA bound to PALB2-DBD, suggesting a novel strand exchange mechanism. Bioinformatics analysis and preliminary observations indicate that PALB2 forms protein-nucleic acids condensates. Intrinsically disordered DBDs are prevalent in the human proteome. PALB2-DBD and similar IDRs may use a chaperone-like mechanism to aid formation and resolution of DNA and RNA multichain intermediates during DNA replication, repair and recombination.
Atomistic characterization of β2-glycoprotein I domain V interaction with anionic membranes
Atomistic characterization of β2-glycoprotein I domain V interaction with anionic membranes
Interaction of β-glycoprotein I (βGPI) with anionic membranes is crucial in antiphospholipid syndrome (APS), implicating the role of its membrane-binding domain, domain V (DV). The mechanism of DV binding to anionic lipids is not fully understood.
Mechanistic basis of activation and inhibition of protein disulfide isomerase by allosteric antithrombotic compounds
Mechanistic basis of activation and inhibition of protein disulfide isomerase by allosteric antithrombotic compounds
Protein disulfide isomerase (PDI) is a promising target for combating thrombosis. Extensive research over the past decade has identified numerous PDI-targeting compounds. However, limited information exists regarding how these compounds control PDI activity, which complicates further development.
Erratum to ‘Illustrated State-of-the-Art Capsules of the ISTH 2024 Congress’ [Research and Practice in Thrombosis and Haemostasis Volume 8, Issue 4, May 2024, 102432]
Erratum to ‘Illustrated State-of-the-Art Capsules of the ISTH 2024 Congress’ [Research and Practice in Thrombosis and Haemostasis Volume 8, Issue 4, May 2024, 102432]
[This corrects the article DOI: 10.1016/j.rpth.2024.102432.].